2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride

We are 2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride CAS:953789-37-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride
CAS.NO:953789-37-2
Synonyms:2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride
2-chloro-N-[2-(4-chlorophenyl)ethyl]propan-1-amine,hydrochloride
2-Chloro-N-[2-(4-chlorophenyl)ethyl]-1-propanamine hydrochloride
 
Physical and Chemical Properties:
Molecular Formula C11H16Cl3N
Molecular Weight 268.610
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Lorcaserin Hydrochloride(CAS:846589-98-8).

2-Chloro-N-(4-chlorophenethyl)propan-1-amine hydrochloride


Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.1066-97-3 As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.(10-Phenylanthracen-9-yl)boronic acid CAS:334658-75-2 The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.3-AMINO-2,6-DIFLUOROBENZOIC ACID The injection has previously proven to be as effective as standard daily pills with three active ingredients when administered monthly and also once every two months.Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.

Related Products
Product Name
2,3-Dimethylbenzonitrile View Details
1,10-Diiododecane View Details
1-Bromo-3-iodobenzene View Details
dAMP manufacturer 3-BAEPF manufacturer 4′-tert-Butyl-4-chlorobutyrophenone manufacturer 3-methylthiopropanol manufacturer 4-Fluoro-3-(trifluoromethyl)aniline manufacturer